| Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation J Pidala, SJ Lee, KW Ahn, S Spellman, HL Wang, M Aljurf, M Askar, ... Blood, The Journal of the American Society of Hematology 124 (16), 2596-2606, 2014 | 294 | 2014 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 253 | 2017 |
| Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a Center for International Blood and Marrow Transplant Research Study A D'Souza, A Dispenzieri, B Wirk, MJ Zhang, J Huang, MA Gertz, RA Kyle, ... Journal of Clinical Oncology 33 (32), 3741-3749, 2015 | 211 | 2015 |
| Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma JM Logue, E Zucchetti, CA Bachmeier, GS Krivenko, V Larson, D Ninh, ... Haematologica 106 (4), 978, 2021 | 190 | 2021 |
| High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma EA Dean, RS Mhaskar, H Lu, MS Mousa, GS Krivenko, A Lazaryan, ... Blood Advances 4 (14), 3268-3276, 2020 | 171 | 2020 |
| Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma MD Jain, H Zhao, X Wang, R Atkins, M Menges, K Reid, K Spitler, ... Blood, The Journal of the American Society of Hematology 137 (19), 2621-2633, 2021 | 170 | 2021 |
| Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation M Hamadani, PN Hari, Y Zhang, J Carreras, G Akpek, MD Aljurf, E Ayala, ... Biology of Blood and Marrow Transplantation 20 (11), 1729-1736, 2014 | 159 | 2014 |
| Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma LJ Costa, MJ Zhang, X Zhong, A Dispenzieri, S Lonial, A Krishnan, ... Biology of Blood and Marrow Transplantation 19 (11), 1615-1624, 2013 | 130 | 2013 |
| Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma A Saad, A Mahindra, MJ Zhang, X Zhong, LJ Costa, A Dispenzieri, ... Biology of Blood and Marrow Transplantation 20 (3), 402-408. e1, 2014 | 124 | 2014 |
| Salvage second hematopoietic cell transplantation in myeloma LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ... Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013 | 123 | 2013 |
| Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse MA Kharfan-Dabaja, M Labopin, E Polge, T Nishihori, A Bazarbachi, ... JAMA oncology 4 (9), 1245-1253, 2018 | 121 | 2018 |
| Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis SR Goldsmith, MB Abid, JJ Auletta, A Bashey, A Beitinjaneh, P Castillo, ... Blood, The Journal of the American Society of Hematology 137 (23), 3291-3305, 2021 | 118 | 2021 |
| Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies I Abu-Dalle, T Reljic, T Nishihori, A Antar, A Bazarbachi, B Djulbegovic, ... Biology of Blood and Marrow Transplantation 20 (11), 1677-1686, 2014 | 115 | 2014 |
| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 114 | 2019 |
| Improved survival after acute graft-versus-host disease diagnosis in the modern era HJ Khoury, T Wang, MT Hemmer, D Couriel, A Alousi, C Cutler, M Aljurf, ... haematologica 102 (5), 958, 2017 | 111 | 2017 |
| Race/ethnicity affects the probability of finding an HLA-A,-B,-C and-DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization J Pidala, J Kim, M Schell, SJ Lee, R Hillgruber, V Nye, E Ayala, M Alsina, ... Bone marrow transplantation 48 (3), 346-350, 2013 | 111 | 2013 |
| Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation MA Kharfan-Dabaja, HM Lazarus, T Nishihori, RA Mahfouz, M Hamadani Biology of Blood and Marrow Transplantation 19 (7), 1006-1012, 2013 | 104 | 2013 |
| A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation J Pidala, J Kim, H Jim, MA Kharfan-Dabaja, T Nishihori, HF Fernandez, ... Haematologica 97 (12), 1882, 2012 | 101 | 2012 |
| Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and … D Buchbinder, DL Kelly, RF Duarte, JJ Auletta, N Bhatt, M Byrne, ... Bone marrow transplantation 53 (5), 535-555, 2018 | 98 | 2018 |
| The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia M Yeshurun, D Weisdorf, JM Rowe, MS Tallman, MJ Zhang, HL Wang, ... Blood advances 3 (4), 670-680, 2019 | 92 | 2019 |
